source
- AstraZeneca reports promising triplet therapy results in liver cancer subgroupAstraZeneca presented new data at ASCO 2026 showing that a regimen combining a targeted agent with two immunotherapies produced clinical benefit in a subset of liver cancer patients. The study eva…
- Eli Lilly gives hospitals five days to submit 340B claims data or lose discount pricingEli Lilly has issued a notice to more than 1,000 hospitals that take part in the federal 340B drug discount program, requiring them to provide comprehensive claims data within five days. The compa…